Nuclear factor-κB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis

Molecular Pharmacology

Volumn 67, Issue 4, 2005, Pages 1018-1025

  Matsuda, Naoyuki ^a   Hattori, Yuichi ^a   Jesmin, Subrina ^a   Gando, Satoshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; CYCLOOXYGENASE 2; FR 260330; HISTAMINE H1 RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OLIGODEOXYNUCLEOTIDE; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; UNCLASSIFIED DRUG; OLIGODEOXYRIBONUCLEOTIDE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GAS; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; GAS EXCHANGE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; LUNG INJURY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PARAINFLUENZA VIRUS 1; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; SEPSIS; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; DISEASE MODEL; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; LIGATION; LUNG; MALE; PATHOLOGY; PUNCTURE;

ANIMALS; DISEASE MODELS, ANIMAL; LIGATION; LUNG; MALE; MICE; MICE, INBRED ICR; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; PUNCTURES; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS;

EID: 15744394565     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.005926     Document Type: Article

References (41)

1. Baker CC, Chaudry IH, Gaines HO, and Baue AE (1983) Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model. Surgery 94:331-335.
2. Bäurle PA and Baltimore D (1996) NF-κB: ten years after. Cell 87:13-20.
3. Bäurle PA and Henkel T (1994) Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179.
4. Beckman JS and Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-C1437.
5. Bielins A, Schivdasani RA, Zhang I, and Nabel GJ (1990) Regulation of gene expression with double stranded phosphorothioate oligonucleotides. Science (Wash DC) 250:997-1000.
6. Brigham KL, Padove SJ, Bryant D, McKeen CR, and Bowers RE (1980) Diphenhydramine reduces endotoxin effects on lung vascular permeability in sheep. J Appl Physiol 49:516-520.
7. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, and Maniatis T (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 9:899-909.
8. Fernandez de Arriba A, Cavalcanti F, Miralles A, Bayon Y, Alonso A, Merlos M, Garcia-Rafanell J, and Forn J (1999) Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid. Mol Pharmacol 55:753-760.
9. Griffin MP, Gore DC, Lobe TE, Flynn JF, Traber DL, and Herndon DN (1991) Ibuprofen therapy in experimental porcine Gram-negative septic shock. Resuscitation 22:75-83.
10. Heremans H, Dillen C, Groenen M, Matthys P, and Billiau A (2000) Role of interferon-gamma and nitric oxide in pulmonary edema and death induced by lipopolysaccharide. Am J Respir Crit Care Med 161:110-117.
11. Hinder F, Stubbe HD, van Aken H, Waurick R, Booke M, and Meyer J (1999) Role of nitric oxide in sepsis-associated pulmonary edema. Am J Respir Crit Care Med 159:252-257.
12. Humphrey DM, McManus LM, Hanahan DJ, and Pinckard RN (1984) Morphologic basis of increased vascular permeability induced by acetyl glyceryl ethyl phosphorylcholine. Lab Invest 50:16-25.
13. Kaneda Y, Nakajima T, Nishikawa T, Yamamoto S, Ikegami H, Suzuki N, Nakamura H, Morishita R, and Kotani H (2002) Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther 6:219-226.
14. Kopp E and Ghosh S (1994) Inhibition of NF-κB by sodium salicylate and aspirin. Science (Wash DC) 265:956-959.
15. Kristof AS, Goldberg P, Laubach V, and Hussain SNA (1998) Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 158:1883-1889.
16. Laneuville O, Breuer DK, CeWitt DL, Hla T, Funk CD, and Smith WL (1994) Differential inhibition of human prostaglandin endoperoxide H synthase-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 271:927-934.
17. Lechin AE and Varon J (1994) Adult respiratory syndrome (ARDS): the basics. J Emerg Med 12:63-68.
18. Li Q and Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725-734.
19. sα in septic rabbits. Anesthesiology 93:1465-1473.
20. 1-adrenoceptor mRNA expression in rat heart. Biochem Pharmacol 58:881-885.
21. 2-receptor gene expression during endotoxemia. Naunyn-Schmiedeberg's Arch Pharmacol 366:513-521.
22. Matsuda N, Hattori Y, Takahashi Y, Nishihira J, Jesmin S, Kobayashi M, and Gando S (2004a) Therapeutic effect of in vivo transfection of transcription factor decoy to NF-κB on septic lung in mice. Am J Physiol 287:L1248-L1255.
23. 2 receptor gene and protein levels are differentially expressed in the hearts of rodents and humans. J Pharmacol Exp Ther 309:786-795.
24. Moncada S and Higgs EA (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9:1319-1330.
25. Montrucchio G, Alloatti G, and Camussi G (2000) Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 80:1669-1699.
26. Morishita R, Sugimoto T, Aoki M, Kita I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki T, et al. (1997) In vivo transfection of cis element "decoy" against nuclear factor-κB binding site prevents myocardial infarction. Nature (Lond) Med 8:894-899.
27. Nathens AB, Bitar R, Davreux C, Bujard M, Marshall JC, Dackiw APB, Watson RW, and Rotstein OD (1997) Pyrrolidine dithiocarbamate attenuates endotoxin-induced acute lung injury. Am J Respir Cell Mol Biol 17:608-616.
28. 1 receptor gene in inflammation. J Biol Chem 273:2784-2791.
29. Nuckton TJ, Alonso JA, Kallet RH, Daniel BM, Pittet JT, Eisner MD, and Matthay MA (2002) Pulmonary dead-space fractions as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 346:1281-1286.
30. Phagoo SB, Yaqoob M, Herrera-Martinez E, McIntyre P, Jones C, and Burgess GM (2000) Regulation of bradykinin receptor gene expression in human lung fibroblasts. Eur J Pharmacol 397:237-246.
31. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, and Gerritsen ME (1997) Novel inhibitor of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272:21096-21103.
32. Pittet JF, Mackersie RC, Martin TR, and Matthay MA (1997) Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 155:1187-1205.
33. Regoli D, Jukic D, Gobeil F, and Rhaleb N-E (1993) Receptors for bradykinin and related kinins: a critical analysis. Can J Physiol Pharmacol 71:56-567.
34. Russell DA, Tucker KK, Chinookoswong N, Thompson RC, and Kohno T (1995) Combined inhibition of interleukin-1 and tumor necrosis factor in rodent endotoxemia: improved survival and organ function. J Infect Dis 171:1528-1538.
35. Sheehan M, Wong HR, Hake PW, Malhotra V, O'Connor M, and Zingarelli B (2002) Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents. Mol Pharmacol 61:953-963.
36. Ullrich R, Bloch KD, Ichinose F, Steudel W, and Zapol WM (1999) Hypoxic pulmonary blood flow distribution and arterial oxygenation in endotoxin-challenged NOS2-deficient mice. J Clin Investig 104:1421-1429.
37. Villar J, Ribeiro SP, Mullen JB, Kuliszewski M, Post M, and Slutsky AS (1994) Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model. Crit Care Med 22:914-921.
38. Weimann J, Bloch KD, Takata M, Steudel W, and Zapol WM (1999) Congenital NOS2 deficiency protects mice from LPS-induced hyporesponsiveness to inhaled nitric oxide. Anesthesiology 91:1744-1753.
39. Worrall NK, Chang K, LeJeune WS, Misko TP, Sullivan PM, Ferguson TB Jr, and Williamson JR (1997) TNF-α causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms. Am J Physiol 273: H2565-H2574.
40. Xie Q, Kashiwabara Y, and Nathan C (1994) Role of transcription factor NF-κB/Rel in induction of nitric oxide. J Biol Chem 269:4705-4708.
41. Yamamoto K, Arakawa T, Ueda N, and Yamamoto S (1995) Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 270: 31315-31320.